Short Interest in TRxADE HEALTH, Inc. (NASDAQ:MEDS) Decreases By 31.0%

TRxADE HEALTH, Inc. (NASDAQ:MEDS) saw a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 6,900 shares, a drop of 31.0% from the May 31st total of 10,000 shares. Currently, 1.4% of the company’s shares are sold short. Based on an average trading volume of 97,200 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in TRxADE HEALTH stock. Virtu Financial LLC acquired a new position in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned about 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the stock is owned by institutional investors and hedge funds.

TRxADE HEALTH Price Performance

MEDS traded down $1.99 during mid-day trading on Friday, hitting $11.17. 175,920 shares of the stock were exchanged, compared to its average volume of 263,833. The firm’s fifty day moving average is $6.95 and its two-hundred day moving average is $8.15. TRxADE HEALTH has a 1-year low of $3.69 and a 1-year high of $44.56.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.